Moderna Company Declares That Its Covid-19 Vaccine Performs Well in Children
Moderna, Inc. declared interim results of its Covid-19, a vaccine for children under six, on Wednesday. The company claimed that two doses of 25-micrograms of its Covid-19 vaccine for the children ages from six months through five years old, gave the same immune response to two 100-microgram shots for adults ages between 18 to 25 […]
Continue Reading